Elicio Therapeutics Inc. (ELTX) — Financial Flexibility Index
Elicio Therapeutics Inc. (ELTX) has a Financial Flexibility Index of -0.35x as of June 2026. Free cash flow of $-8.16 Million (operating CF $-8.16 Million minus capex $0.00) represents 0% of total liabilities ($23.39 Million). Check how aggressively does Elicio Therapeutics Inc. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elicio Therapeutics Inc. Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Elicio Therapeutics Inc. across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Elicio Therapeutics Inc..
Annual Financial Flexibility Index for Elicio Therapeutics Inc. (2012–2025)
Year-by-year free cash flow to debt coverage for Elicio Therapeutics Inc.. Explore how well can Elicio Therapeutics Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.52x | $-36.94 Million | $-36.95 Million | $24.23 Million | ▼ -62.8% |
| 2024 | -0.94x | $-36.98 Million | $-37.07 Million | $39.49 Million | ▲ +54.7% |
| 2023 | -2.07x | $-32.63 Million | $-32.69 Million | $15.77 Million | ▼ -32.1% |
| 2022 | -1.57x | $-21.52 Million | $-22.18 Million | $13.75 Million | ▼ -0.3% |
| 2021 | -1.56x | $-23.41 Million | $-23.94 Million | $15.01 Million | ▼ -841.0% |
| 2020 | -0.17x | $-22.85 Million | $-22.89 Million | $137.80 Million | ▲ +79.2% |
| 2019 | -0.80x | $-24.35 Million | $-24.59 Million | $30.47 Million | ▲ +23.1% |
| 2018 | -1.04x | $-8.02 Million | $-8.02 Million | $7.72 Million | ▼ -459.3% |
| 2013 | 0.29x | $1.91 Million | $1.89 Million | $6.60 Million | ▲ +76.5% |
| 2012 | 0.16x | $1.11 Million | $1.07 Million | $6.79 Million | — |